D
CRISPR Therapeutics AG CRSP
$41.86 $3.298.53% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue 71.63% -82.26% -- -99.26% -99.50%
Total Other Revenue -- -- -- -- --
Total Revenue 71.63% -82.26% -- -99.26% -99.50%
Cost of Revenue 5.57% -28.65% -18.23% -9.50% -13.36%
Gross Profit -5.30% -153.99% 18.76% -72.96% -191.11%
SG&A Expenses 7.48% 9.98% -4.77% 2.36% -19.71%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 5.81% -23.81% -16.37% -8.14% -14.22%
Operating Income -5.57% -192.82% 16.83% -58.85% -118.01%
Income Before Tax -16.42% -140.87% 23.87% -62.88% -123.92%
Income Tax Expenses 53.18% 200.43% 112.62% 39.44% -45.15%
Earnings from Continuing Operations -16.64% -141.76% 23.37% -62.60% -119.71%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -16.64% -141.76% 23.37% -62.60% -119.71%
EBIT -5.57% -192.82% 16.83% -58.85% -118.01%
EBITDA -5.84% -180.21% 17.33% -62.21% -128.40%
EPS Basic -11.02% -138.94% 28.60% -51.44% -111.33%
Normalized Basic EPS -10.81% -138.10% 29.07% -51.71% -115.35%
EPS Diluted -10.66% -139.88% 28.48% -51.59% -112.01%
Normalized Diluted EPS -10.81% -138.89% 29.07% -51.71% -115.35%
Average Basic Shares Outstanding 5.07% 7.25% 7.33% 7.37% 3.96%
Average Diluted Shares Outstanding 5.07% 5.09% 7.33% 7.37% 3.96%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --